Gardere Client Rosewood Private Investments Announces Majority Investment in ProTec Laboratory

Gardere client Rosewood Private Investments announced a majority equity investment in ProTec Laboratory, a leading provider of contract manufacturing services to consumer brands in the dietary supplements, sports nutrition, functional foods and pet care products industries.

“By bringing ProTec into the fold, we’ve created a significant platform of scale with enormous potential,” said Paul Richardson, CEO of Rosewood Private Investments’ holding company. “Today, the combined businesses serve well over 100 customers in over 60 markets globally, and we plan to grow far beyond that by focusing on our centers of excellence, as well as through select strategic acquisitions.”

Chris Converse, co-chair of Gardere’s Private Equity Team, and Christopher J. Babcock represented Rosewood Private Investments in the transaction. More information on the deal is available here, and additional background on various Rosewood investments are available via the Dallas Morning News.